BIAF
Conviction 8HealthcareScan · Thu, Sep 24, 2026bioAffinity Technologies, Inc. (BIAF) closed at $7.76 (-2.27%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 49, RS Rating 26, -90.2% from its 52-week high, -57.6% year to date. Sector: Healthcare · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH.
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and historyuk.finance.yahoo.com · Wed, Sep 23, 2026
- bioAffinity Technologies to Showcase Lung Cancer Test Data at Veterans’ Research ConferenceAdvfn · Tue, Sep 22, 2026
- bioAffinity to Highlight CyPath Lung at NAVREF 2026TipRanks · Tue, Sep 22, 2026
- bioAffinity Technologies, Inc.: Material event (8-K)SEC EDGAR · Tue, Sep 22, 2026
- Form 8K bioAffinity Technologies Inc For: 22 September By Investing.comInvesting.com India · Tue, Sep 22, 2026
- bioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual ConferenceYahoo Finance · Tue, Sep 22, 2026
Congress activity
Disclosed STOCK Act trades in BIAF
Insider activity
SEC Form 4 transactions in BIAF
SEC filings
EDGAR filings in BIAF · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.